126 / 194
SPADA Botulinum neurotoxin Working Group
Working Group Members
Shashi Sharma, FDA (Chair)
Linda Beck, NSWC Dahlgren
Mark Poli, USAMRIID
David Rozak, USAMRIID
Ryan Cahall, Censeo Insight
Kenneth Damer, Northrop Grumman
Paul Jackson, LLNL
Matthew Lesho, Luminex
Ri h d O i h PNNL
Sanjiv Shah, US EPA
Theresa Smith, USAMRIID
Shanmuga Sozhamannan, DoD CRP
Nagarajan Thirunavukkarasu, FDA
c ar zan c ,
Botulinum neurotoxin Work to Date
•
Working Group Launch (March, 2016)
•
Three (3) teleconferences (May 2016 – July 2016)
•
1 SMPR Drafted
•
Public comment period (July 15, 2016 – August
12 2016)
,
•
SMPRs made ready for SPADA review and
approval